Loading...
01/11 03:38
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary is generally positive, with strong EPS growth, increased revenue, and a record backlog. Shareholder returns are robust, with a 10% dividend growth and significant share repurchases. The Q&A section reveals confidence in cash flow and growth, despite some concerns about procurement cycles and construction costs. The optimistic guidance and record high revenue, along with strategic capital returns, suggest a positive stock price movement.
Adjusted EPS $1.43, a 22% increase year-over-year due to strong operating performance and capital return strategy.
Adjusted Net Revenue Increased by 3% year-over-year, impacted by a legal reserve and FX headwinds.
Adjusted EBITDA $287 million, representing an 8% year-over-year increase, with margin improvement due to strong gross margin performance and disciplined G&A costs.
Consolidated Backlog Increased by 20% year-over-year to a record $22.2 billion, indicating strong bookings momentum.
Gross Profit in Backlog Increased by 15% year-over-year, reflecting strong quarter for bookings.
Free Cash Flow Negative $114 million, in line with expectations due to seasonal cash timing events.
Share Repurchases $351 million, a quarterly record for Jacobs.
Debt Reduction Reduced outstanding debt by $312 million through an equity for debt transaction.
Dividend $0.32 per share, representing a 10% year-over-year growth.
Total Capital Returned to Shareholders $628 million through repurchases and dividends over the past two quarters.
New Product Development: Jacobs secured an OT cybersecurity contract with Hampton Roads Sanitation District, providing end-to-end cybersecurity for wastewater treatment operations.
Life Sciences Project: Jacobs is engaged in a new engineering procurement and program management work for Merck's $1 billion oncology product facility in Delaware.
Data Center Expansion: Jacobs was selected by PsiQuantum as the owner engineer for a utility-scale quantum computing facility in Brisbane, Australia.
Market Expansion in Water Sector: Jacobs continues to see strong underlying revenue growth in Water, with a focus on addressing emerging contaminants like PFAS.
Growth in Life Sciences and Data Centers: Life Sciences and data centers are primary drivers of revenue growth, both seeing double-digit increases.
Transportation Infrastructure Growth: Jacobs was selected as the owner engineer for Denver International Airport's transportation system expansion.
Operational Efficiency: Jacobs achieved a 22% increase in adjusted EPS, reflecting strong operating performance and margin expansion.
Backlog Growth: Consolidated backlog grew 20% year-over-year to a record $22.2 billion.
Shareholder Returns: Jacobs returned $628 million to shareholders through repurchases and dividends over the past two quarters.
Strategic Shift in Portfolio: Jacobs is focused on redefining the asset life cycle for clients, aligning with high-growth markets.
Geopolitical Positioning: Jacobs remains well positioned amid geopolitical challenges, with infrastructure and consulting services in high demand.
Legal Risks: A reserve was recorded due to a legal matter involving a consolidated joint venture (JV) in which Jacobs has a 50% interest, impacting adjusted net revenue and operating profit significantly.
Supply Chain Challenges: Jacobs is focused on supporting clients in assessing potential supply chain challenges, particularly in light of tariffs and geopolitical uncertainties.
Geopolitical Risks: The current geopolitical backdrop presents uncertainties, although the impact from the rollout of the Department of Government Efficiency (DOGE) has been minimal so far.
Economic Factors: Jacobs anticipates growth opportunities with the US Department of Defense, which constitutes approximately 9% of total revenue, indicating reliance on government spending.
Currency Fluctuations: The company faced adverse impacts from foreign exchange (FX) fluctuations, which affected revenue growth during Q2.
Backlog Growth: Our backlog grew 20% to more than $22 billion, a new record.
Key Project Awards: Secured an OT cybersecurity contract with Hampton Roads Sanitation District and a project for the city of Boynton Beach to design upgrades for water treatment plants.
Focus Areas: Core pillar of our strategy is to redefine the asset life cycle for our clients, with strong emphasis on Water and Environmental, Life Sciences, and Critical Infrastructure.
Investment in PA Consulting: We continue to evaluate increasing our investment in PA Consulting.
Fiscal 2025 Adjusted Net Revenue Growth: We reaffirm our fiscal 2025 outlook for adjusted net revenue to grow mid-to high single digits year-over-year.
Adjusted EBITDA Margin: Adjusted EBITDA margin to range from 13.8% to 14%.
Free Cash Flow Conversion: Reported free cash flow conversion to be more than 100%.
Adjusted EPS Guidance: Adjusted EPS of $5.85 to $6.20.
Q3 Revenue Growth Expectation: Q3 net revenue expected to grow 5% to 7% year-on-year.
Sequential Revenue Growth: We continue to anticipate revenue will rise sequentially through year-end.
Dividend per share: $0.32 per share, representing a 10% year-over-year growth.
Share repurchase: $351 million in shares repurchased during Q2, a quarterly record for Jacobs.
Total capital returned to shareholders: $628 million through repurchases and dividends over the past two quarters.
Future capital returns: Potential to return more than 100% of adjusted free cash flow in fiscal year 2025, excluding the distribution of Amentum shares.
Amentum shares distribution: Distribution of Amentum shares to shareholders on a prorata basis, representing approximately $159 million in incremental capital returns.
The earnings call highlights strong financial performance with raised EPS guidance, revenue growth, and margin expansion. Despite some challenges in the environmental sector, overall growth is robust across regions and sectors, supported by strategic AI partnerships and a strong pipeline, especially in Data Centers. The company's commitment to shareholder returns and positive Q&A insights further reinforce a positive sentiment. However, lack of specific guidance on some aspects and a one-time tax event slightly temper the outlook.
The earnings call summary and Q&A section indicate strong backlog growth, strategic partnerships, and positive guidance for fiscal 2025. Key sectors such as Life Sciences, Data Centers, and Water are expected to drive growth, while margin improvements and organic investments further bolster confidence. Despite some uncertainties, such as the impact of Medicaid cuts, overall sentiment is positive due to robust financial metrics and optimistic outlooks, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
The earnings call summary is generally positive, with strong EPS growth, increased revenue, and a record backlog. Shareholder returns are robust, with a 10% dividend growth and significant share repurchases. The Q&A section reveals confidence in cash flow and growth, despite some concerns about procurement cycles and construction costs. The optimistic guidance and record high revenue, along with strategic capital returns, suggest a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
